Bio-Based Chemicals and Enzymes: A New Frontier in India’s Bioeconomy

Laying the Foundation of a ₹9,197 Crore Bet on Bioeconomy

In 2023, India imported acetic acid worth nearly $480 million to meet industrial demand. The dependency on petrochemical imports for basic intermediates is a glaring vulnerability in the country’s industrial supply chains. Bio-based chemicals, derived from India’s vast agricultural biomass resources, have been proposed as a strategic intervention to address this dependency. This also aligns with larger goals like reducing carbon footprints, enhancing rural incomes, and bolstering industrial competitiveness. Yet, despite the grand rhetoric, the sector’s evolution remains constrained by economic, logistical, and institutional challenges that the BioE3 Policy and the ₹9,197 crore Bio-RIDE scheme cannot solely resolve.

The Policy Architecture: A High-Stakes Push

The Ministry of Science and Technology’s Department of Biotechnology has christened bio-based chemicals and enzymes as priority pillars within the BioE3 (Biotechnology for Economy, Environment, and Employment) framework. This policy emphasises building biomanufacturing hubs, fostering employment through rural bio-industrial clusters, and delivering scalable technologies to the market. Central to this is the Bio-RIDE scheme, which allocates ₹9,197 crore for biotechnology infrastructure, including a dedicated component for biofoundries and demonstration hubs.

The efforts are not merely infrastructural. Capacity-building initiatives, enhanced funding for synthetic biology research, and integration of artificial intelligence in enzyme engineering form part of the government’s roadmap. By targeting rural clusters, where agricultural residues and crop biomass remain underutilised or burnt, the policy also merges environmental goals and rural development. However, as we have learnt from precedents like the troubled ethanol-blending programme, linking rural supply chains to industrial pipelines is fraught with inefficiencies.

The Economics of Bio-Based Chemicals: Detailing the Promise and Peril

India’s vast agricultural footprint generates significant potential feedstock for bio-based chemicals. Crop residues, sugarcane bagasse, and starch-based feedstock are plentiful and could diversify farmer incomes while reducing pollution from stubble burning. Yet these promises hinge on solutions to deeply entrenched challenges.

For one, cost-competitiveness remains elusive. Early-stage production costs of bio-based chemicals and enzymes significantly exceed their petrochemical alternatives. For example, bio-alcohols produced through fermentation are often 15-25% costlier than fossil-based alcohol intermediates. Unless subsidies or carbon market incentives narrow this gap, private sector uptake will remain tepid.

Second, logistical inefficiencies in ensuring a predictable, sustainable biomass supply persist. Competing demands from food production and animal feed markets mean bio-manufacturing ventures often face volatile raw material input costs. India’s recent experience with ethanol blending demonstrates the pitfalls of relying on uncoordinated feedstock supply chains.

Furthermore, while bio-based chemicals align with net-zero ambitions, their life-cycle carbon accounting standards remain poorly defined in India. Without robust frameworks for certification and traceability, industrial demand may view such inputs as regulatory risks rather than sustainable alternatives.

Comparative Lessons from China

India’s policy aspirations are ambitious, but they pale in comparison to China’s structured bioeconomy strategy. The Chinese government has explicitly prioritised bio-based chemicals and enzyme technologies in its industrial policy and allocated significant public R&D funding through state-owned entities and academia. Crucially, China also mandates mandatory adoption mechanisms for high-value bio-based chemicals by large manufacturers. The result? China controls over 60% of the global bio-based lactic acid market, driven by seamless integration of research, scale-up facilities, and industrial application.

Unlike India’s fragmented BioE3 framework, China’s National Development and Reform Commission oversees multi-agency coordination that pools investments into feedstock resilience, high-quality synthetic biology, and export-oriented manufacturing hubs. For India, the gap lies as much in weak inter-ministerial coordination as in resource allocation.

Structural Tensions and Institutional Critique

The vision of bio-based chemicals serving both rural income diversification and industrial competitiveness faces several structural tensions. India’s federal system complicates the bioeconomy’s growth, as the biomass supply chains inherently depend on state-level agricultural and land-use policies. For smaller states like Punjab, where stubble management is already a contentious policy area, the feasibility of allocating crop residues for bio-industrial use remains unclear.

Moreover, the emphasis on biomanufacturing infrastructure under the Bio-RIDE scheme risks repeating the pitfalls of India’s past infrastructure-led policies. Without clear mechanisms for risk-sharing, such as those present in the EU’s Bioeconomy Strategy and Action Plan, private sector players may remain reluctant to invest in expensive pilot plants. The lack of standardised regulatory processes for certifying bio-based chemicals creates uncertainties that could inhibit market adoption — a similar issue that beleaguered India’s slow adoption of electric vehicles until 2020 policy interventions.

Towards a Viable Bio-Based Economy: Beyond Paper Commitments

For India’s bio-based chemical ambitions to succeed, several foundational issues demand focused interventions. Shared biomanufacturing hubs are crucial, but they must be supported by targeted subsidies, streamlined regulatory clearances, and vastly improved biomass supply chain logistics. Investments in synthetic biology and enzyme engineering — flagged as priorities by the BioE3 framework — demand timelines and accountability, lest they languish in research siloes with limited translational value.

Additionally, India may need to adopt certain policy mechanisms from the U.S. — such as the BioPreferred Program, which mandates federal procurement preference for bio-certified products. This would provide predictable market demand and incentivise bio-based chemical adoption domestically.

Finally, success will depend on India recognising that large-scale biomass utilisation requires not just infrastructure spending but agreements on sustainable land-use practices with states, farmer cooperatives, and rural industries. These tensions, if unresolved, will leave the country far short of the transformative vision articulated by BioE3.

Practice Questions for UPSC

Prelims Practice Questions

Frequently Asked Questions